Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0106 USD | -3.18% | +7.00% | -43.68% |
04-16 | AXIM Biotechnologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-15 | AXIM Biotechnologies, Inc. announced that it has received $0.814555 million in funding | CI |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
3.1M | - | - | - | - | - | |
63.85B | - | |||||
41.83B | ||||||
40.65B | ||||||
27.12B | ||||||
26.52B |